Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose

Jennifer Hislop, Graham Mowatt, Pawana Sharma, Cynthia Fraser, Andrew Elders, David Jenkinson, Luke Vale, Russell Petty

Research output: Contribution to journalArticle

13 Citations (Scopus)
4 Downloads (Pure)
Original languageEnglish
Pages (from-to)168-176
Number of pages9
JournalJournal of Gastrointestinal Cancer
Volume43
Issue number2
Early online date6 Oct 2011
DOIs
Publication statusPublished - Jun 2012

Keywords

  • GIST
  • gastrointestinal stromal tumours
  • unresectable
  • metastatic
  • cancer
  • imatinib
  • sunitinib
  • antineoplastic agents
  • benzamides
  • clinical trials as topic
  • disease progression
  • dose-response relationship
  • gastrointestinal stromal tumors
  • humans
  • indoles
  • piperazines
  • pyrimidines
  • pyrroles
  • treatmemnt outcome

Cite this

Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose. / Hislop, Jennifer; Mowatt, Graham; Sharma, Pawana; Fraser, Cynthia; Elders, Andrew; Jenkinson, David; Vale, Luke; Petty, Russell.

In: Journal of Gastrointestinal Cancer, Vol. 43, No. 2, 06.2012, p. 168-176.

Research output: Contribution to journalArticle

@article{220ee7d835d94225b8f31ba7e6dbe804,
title = "Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose",
keywords = "GIST, gastrointestinal stromal tumours, unresectable, metastatic, cancer, imatinib, sunitinib, antineoplastic agents, benzamides, clinical trials as topic, disease progression, dose-response relationship, gastrointestinal stromal tumors, humans, indoles, piperazines, pyrimidines, pyrroles, treatmemnt outcome",
author = "Jennifer Hislop and Graham Mowatt and Pawana Sharma and Cynthia Fraser and Andrew Elders and David Jenkinson and Luke Vale and Russell Petty",
note = "PMID: 21971958 [PubMed - indexed for MEDLINE] PMCID: PMC3348468 Free PMC Article This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited",
year = "2012",
month = "6",
doi = "10.1007/s12029-011-9325-6",
language = "English",
volume = "43",
pages = "168--176",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Systematic Review of Escalated Imatinib Doses Compared with Sunitinib or Best Supportive Care, for the Treatment of People with Unresectable/Metastatic Gastrointestinal Stromal Tumours Whose Disease has Progressed on the Standard Imatinib Dose

AU - Hislop, Jennifer

AU - Mowatt, Graham

AU - Sharma, Pawana

AU - Fraser, Cynthia

AU - Elders, Andrew

AU - Jenkinson, David

AU - Vale, Luke

AU - Petty, Russell

N1 - PMID: 21971958 [PubMed - indexed for MEDLINE] PMCID: PMC3348468 Free PMC Article This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited

PY - 2012/6

Y1 - 2012/6

KW - GIST

KW - gastrointestinal stromal tumours

KW - unresectable

KW - metastatic

KW - cancer

KW - imatinib

KW - sunitinib

KW - antineoplastic agents

KW - benzamides

KW - clinical trials as topic

KW - disease progression

KW - dose-response relationship

KW - gastrointestinal stromal tumors

KW - humans

KW - indoles

KW - piperazines

KW - pyrimidines

KW - pyrroles

KW - treatmemnt outcome

U2 - 10.1007/s12029-011-9325-6

DO - 10.1007/s12029-011-9325-6

M3 - Article

VL - 43

SP - 168

EP - 176

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 2

ER -